Duell, J., Maddocks, K. J., González-Barca, E., Jurczak, W., Liberati, A. M., de Vos, S., Nagy, Z., Obr, A., Gaidano, G., Abrisqueta, P., Kalakonda, N., André, M., Dreyling, M., Menne, T., Tournilhac, O., Augustin, M., Rosenwald, A., Dirnberger-Hertweck, M., Weirather, J., Ambarkhane, S. and Salles, G. (2020) “Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2021.279802.